Synonyms: compound 2 [PMID: 18281931] | EVG | GS-9137 | GS9137 | JTK-303 | JTK303 | Vitekta®
elvitegravir is an approved drug (EMA (2013), FDA (2014), UK (2021))
Compound class:
Synthetic organic
Comment: Elvitegravir (GS-9137) is an HIV integrase inhibitor antiretroviral drug [1].
|
|
Classification | |
Compound class | Synthetic organic |
Approved drug? | Yes (EMA (2013), FDA (2014), UK (2021)) |
International Nonproprietary Names | |
INN number | INN |
8871 | elvitegravir |
Synonyms |
compound 2 [PMID: 18281931] | EVG | GS-9137 | GS9137 | JTK-303 | JTK303 | Vitekta® |
Database Links | |
BindingDB Ligand | 50183273 |
CAS Registry No. | 697761-98-1 (source: WHO INN record) |
ChEMBL Ligand | CHEMBL204656 |
DrugBank Ligand | DB09101 |
GtoPdb PubChem SID | 441604946 |
PubChem CID | 5277135 |
RCSB PDB Ligand | ELV |
Search Google for chemical match using the InChIKey | JUZYLCPPVHEVSV-LJQANCHMSA-N |
Search Google for chemicals with the same backbone | JUZYLCPPVHEVSV |
Search PubMed clinical trials | elvitegravir |
Search PubMed titles | elvitegravir |
Search PubMed titles/abstracts | elvitegravir |
UniChem Compound Search for chemical match using the InChIKey | JUZYLCPPVHEVSV-LJQANCHMSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | JUZYLCPPVHEVSV-LJQANCHMSA-N |